CDRH director e-mail
This article was originally published in The Gray Sheet
FDA Center for Devices and Radiological Health Director David Feigal is now receiving comments and concerns directly through the e-mail address "email@example.com," Elizabeth Jacobson tells the Food & Drug Law Institute on Dec. 16. The center plans to work with FDLI to allow companies to correspond anonymously through the address, Jacobson says
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.